Technical Analysis for AMRN - Amarin Corporation plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical AMRN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Fell Below 200 DMA | Bearish | -1.89% | |
| Lower Bollinger Band Walk | Weakness | -1.89% | |
| Wide Bands | Range Expansion | -1.89% | |
| Below Lower BB | Weakness | -1.89% | |
| Down 3 Days in a Row | Weakness | -1.89% | |
| Down 4 Days in a Row | Weakness | -1.89% | |
| Down 5 Days in a Row | Weakness | -1.89% | |
| Lower Bollinger Band Touch | Weakness | -1.89% | |
| Oversold Stochastic | Weakness | -1.89% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Down 5% | about 6 hours ago | |
| 60 Minute Opening Range Breakdown | about 7 hours ago | |
| Down 3% | about 9 hours ago | |
| Down 2 % | about 10 hours ago | |
| Down 1% | about 10 hours ago |
Get a Trading Assistant
- Earnings date: 02/25/2021
Amarin Corporation plc Description
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Acid Organic Compounds Therapeutic Product Cardiovascular Disease Lipid Therapeutic Products Acids Nutrition Vascular Diseases Cardiovascular Diseases Cholesterol Icos Fatty Acid Lipoprotein Fatty Acids Lipids Triglyceride Low Density Lipoprotein Hypertriglyceridemia Polyunsaturated Fat Saturated Fat
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.7 |
| 52 Week Low | 3.36 |
| Average Volume | 7,968,958 |
| 200-Day Moving Average | 5.96 |
| 50-Day Moving Average | 6.63 |
| 20-Day Moving Average | 7.36 |
| 10-Day Moving Average | 6.70 |
| Average True Range | 0.48 |
| ADX | 34.6 |
| +DI | 15.42 |
| -DI | 37.38 |
| Chandelier Exit (Long, 3 ATRs ) | 7.81 |
| Chandelier Exit (Short, 3 ATRs ) | 6.84 |
| Upper Bollinger Band | 9.06 |
| Lower Bollinger Band | 5.67 |
| Percent B (%b) | 0.02 |
| BandWidth | 46.02 |
| MACD Line | -0.26 |
| MACD Signal Line | 0.03 |
| MACD Histogram | -0.2944 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.53 | ||||
| Resistance 3 (R3) | 6.52 | 6.23 | 6.40 | ||
| Resistance 2 (R2) | 6.23 | 6.03 | 6.24 | 6.35 | |
| Resistance 1 (R1) | 5.98 | 5.90 | 5.84 | 5.99 | 6.30 |
| Pivot Point | 5.69 | 5.69 | 5.62 | 5.70 | 5.69 |
| Support 1 (S1) | 5.44 | 5.49 | 5.30 | 5.45 | 5.14 |
| Support 2 (S2) | 5.15 | 5.36 | 5.16 | 5.09 | |
| Support 3 (S3) | 4.90 | 5.15 | 5.05 | ||
| Support 4 (S4) | 4.91 |
